Literature DB >> 27784587

Low-Intensity Extracorporeal Shock Wave Therapy in Vascular Disease and Erectile Dysfunction: Theory and Outcomes.

Ilan Gruenwald1, Noam D Kitrey1, Boaz Appel1, Yoram Vardi2.   

Abstract

INTRODUCTION: Low-intensity extracorporeal shock wave therapy (LI-ESWT) to the penis has recently emerged as a new and promising modality in the treatment of erectile dysfunction (ED). AIM: To review the published literature on the mechanism of action of LI-ESWT; and to report our clinical data on its efficacy in men with vasculogenic ED.
METHODS: A Medline search using the relevant keywords on this topic has been done.
RESULTS: From the results of numerous preclinical and animal studies that have been done to date, sufficient evidence shows that the underlying mechanism of action of LI-ESWT is probably neovascularization. Therefore, local application of LI-ESWT to the corpora cavernosa may potentially act in the same mechanism and increase corporal blood flow. We found that the application of LI-ESWT to patients who responded to oral therapy (PDE5i) eliminated their dependence on PDE5i and they were able to successfully achieve erections and vaginal penetration (60-75%). Furthermore, PDE5i non-responders became responders and capable of vaginal penetration (72%). Additionally, LI-ESWT resulted in long-term improvement of the erectile mechanism.
CONCLUSIONS: LI-ESWT has the potential to improve and permanently restore erectile function by reinstating the penile blood flow. Although these results on LI-ESWT are promising, further multi- centered studies with longer follow-up are needed to confirm these findings. Gruenwald I, Kitrey ND, Appel B, and Vardi Y. Stem low-intensity extracorporeal shock wave therapy in vascular disease and erectile dysfunction: Theory and outcomes. Sex Med Rev 2013;1:83-90.
Copyright © 2013 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erectile Dysfunction; Low‐Intensity Extracorporeal Shock Waves; Therapy

Year:  2015        PMID: 27784587     DOI: 10.1002/smrj.9

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  8 in total

Review 1.  Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?

Authors:  Mikkel Fode; Georgios Hatzichristodoulou; Ege Can Serefoglu; Paolo Verze; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2017-07-25       Impact factor: 14.432

2.  Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial.

Authors:  Jose Vinay; Daniel Moreno; Osvaldo Rajmil; Eduard Ruiz-Castañe; Josvany Sanchez-Curbelo
Journal:  World J Urol       Date:  2020-07-21       Impact factor: 4.226

Review 3.  An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy.

Authors:  Shazli Azmi; Ioannis N Petropoulos; Maryam Ferdousi; Georgios Ponirakis; Uazman Alam; Rayaz A Malik
Journal:  F1000Res       Date:  2019-02-15

4.  Editorial Comment: Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations.

Authors:  Rodrigo R Vieiralves
Journal:  Int Braz J Urol       Date:  2020 Jan-Feb       Impact factor: 1.541

5.  Comparison of the efficacy and safety of low-intensity extracorporeal shock wave therapy versus on-demand sildenafil for erectile dysfunction.

Authors:  Qi Lei; Dong Wang; Chunhui Liu; Zhigang Ji; Su Yan
Journal:  Transl Androl Urol       Date:  2021-02

6.  Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors.

Authors:  Amado Bechara; Adolfo Casabé; Walter De Bonis; Pablo Gomez Ciciclia
Journal:  Sex Med       Date:  2016-07-18       Impact factor: 2.491

7.  Long-term effectiveness and predictors of success of low-intensity shockwave therapy in phosphodiesterase type 5 inhibitors non-responders.

Authors:  Zubairu S Musa; Ahmed El-Assmy; Ahmad M Shokry; Ahmed A Shokeir; Tamer Zween; Mahmoud R Al-Kenawy
Journal:  Arab J Urol       Date:  2019-11-11

Review 8.  Novel Emerging Therapies for Erectile Dysfunction.

Authors:  Soyeun Kim; Min Chul Cho; Sung Yong Cho; Hong Chung; Mahadevan Raj Rajasekaran
Journal:  World J Mens Health       Date:  2020-03-16       Impact factor: 5.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.